BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
See today's BioWorld Asia
Home
» In the clinic for Aug. 10-16, 2021
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
In the clinic for Aug. 10-16, 2021
Aug. 17, 2021
No Comments
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Atea, Athersys, Azurrx, Bavarian Nordic, Biontech, Daiichi Sankyo, Gigagen, I-Mab, Immvira, Innovation, Innovent, Lynk, Nrx, Opthea, Pfizer, Sinovac, Valneva.
BioWorld Asia
Briefs
In the clinic